Evidence map›Paper›PMID 40601477›Full record

ArticleeLife2025

Negative regulation of miRNA sorting into EVs is mediated by the capacity of RBP PCBP2 to impair the SYNCRIP-dependent miRNA loading.

Francesco Marocco, Sabrina Garbo, Claudia Montaldo, Alessio Colantoni, Luca Quattrocchi, Gioele Gaboardi, Giovanna Sabarese, Carla Cicchini, Mario Lecce, Alessia Carnevale and 4 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. 5EU-Based Tracking of RNA Transfer Through Extracellular Vesicles.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Francesco Marocco *Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0002-4836-057X
Sabrina Garbo *Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0001-7192-0013
Claudia MontaldoNational Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy.
Alessio ColantoniBiology and Biotechnology Department C. Darwin, Sapienza University of Rome, Rome, Italy.
Luca QuattrocchiIstituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.
Gioele GaboardiIstituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.
Giovanna SabareseAnatomical Pathology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.ORCID https://orcid.org/0000-0002-6841-1610
Carla CicchiniIstituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.
Mario LecceIstituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.
Alessia CarnevaleIstituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.
Rossella PaoliniIstituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.
Gian Gaetano TartagliaCenter for Human Technologies, Istituto Italiano di Tecnologia, Genoa, Italy.
Cecilia Battistelli *Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.ORCID https://orcid.org/0000-0002-5611-7377
Marco Tripodi *Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Department of Excellence 2023-2027, Sapienza University of Rome, Rome, Italy.

Funding

Associazione Italiana per la Ricerca sul Cancro IG24955Associazione Italiana per la Ricerca sul Cancro IG26290European Research Council 10.3030/855923European Research Council RIBOMYLOME_309545H2020 European Research Council 10.3030/727658H2020 European Research Council INFORE_825080Istituto Pasteur-Fondazione Cenci Bolognetti 2020Ministero dell'Università e della Ricerca PRIN: progetti di ricerca di rilevante interesse nazionale-Bando 2022ETPX42Sapienza University of Rome MA12117A5D73CC9CSapienza University of Rome RM12218166AEFC72SEED PNR-Finanziamento di progetti di ricerca su temi di interesse trasversale per il PNR 2021
6 · The paper itself

Abstract

While it is accepted that extracellular vesicles (EVs)-mediated transfer of microRNAs contributes to intercellular communication, the knowledge about molecular mechanisms controlling the selective and dynamic miRNA-loading in EVs is still limited to few specific RNA-binding proteins interacting with sequence determinants. Moreover, although mutagenesis analysis demonstrated the presence/function of specific intracellular retention motifs, the interacting protein/s remained unknown. Here, PCBP2 was identified as a direct interactor of an intracellular retention motif: CLIP coupled to RNA pull-down and proteomic analysis demonstrated that it binds to miRNAs embedding this motif and mutagenesis proved the binding specificity. Notably, PCBP2 binding requires SYNCRIP, a previously characterized miRNA EV-loader as indicated by SYNCRIP knock-down. SYNCRIP and PCBP2 may contemporarily bind to miRNAs as demonstrated by EMSA assays and PCBP2 knock-down causes EV loading of intracellular microRNAs. This evidence highlights that multiple proteins/miRNA interactions govern miRNA compartmentalization and identifies PCBP2 as a dominant inhibitor of SYNCRIP function in murine hepatocytes.

Indexed as

Extracellular VesiclesMicroRNAsRNA-Binding ProteinsAnimalsHepatocytesHumansMiceProtein BindingMicroRNAsPCBP2 protein, humanPcbp2 protein, mouseRNA-Binding Proteinscell biologyextracellular vesiclesmiRNAmouseRNA-binding proteins

Identifiers

PMID40601477
PMCPMC12221297

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.